Clinical Event Reductions by ASCVD Risk Score in Hypertension Patients treated with Renal Denervation: A Model-based Estimate based on 3-Year Data from the Global Symplicity Registry
Jan B. Pietzsch, PhD, Wing Tech Inc., Menlo Park, CA, Roland E. Schmieder, MD, University Hospital Erlangen, Erlangen, Germany, Felix Mahfoud, MD, Universität des Saarlandes, Homburg/Saar, Germany, Bryan Williams, MD, Institute of Cardiovascular Sciences, University College London,, London, United Kingdom, Giuseppe Mancia, MD, University of Milano-Bicocca and Policlinico di Monza, Monza, Italy, Krzystzof Narkiewicz, MD, PhD, Medical University of Gdansk, Gdansk, Poland, Luis Ruilope, MD, PhD, Hospital Universitario 12 de Octubre and CIBERCV and School of Doctoral Studies and Research, Universidad Europea de Madrid, Madrid, Spain, Markus Schlaich, MD, Dobney Hypertension Centre, School of Medicine–Royal Perth Hospital Unit, The University of Western Australia, Perth, Australia and Michael Böhm, MD, Saarland University Hospital, Homburg/Saar, Germany